On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > BUSINESS
BUSINESS
- AstraZeneca, MSD to Copromote Lynparza from July
June 29, 2018
- Nippon Shinyaku’s Sakigake-Designated DMD Med Boosts Dystrophin Protein Production in Clinical Studies
June 29, 2018
- BMS Ties Up with Nagoya Univ. for Immuno-Oncology Biomarker Research
June 29, 2018
- Eliquis Significantly Lowers Stroke Risk vs Warfarin: Real-World Data
June 29, 2018
- Mitsubishi Tanabe, Janssen Revise Copromotion Framework for Stelara
June 29, 2018
- JT, Torii Ditch Pruritus Candidate Development
June 29, 2018
- Takeda Shareholders Strike Down Dissident Group’s Proposal
June 28, 2018
- Japan’s 1st Rituxan Biosimilar Boasts 13% Share: Sandoz Country Head
June 28, 2018
- DPP-4/SGLT2 Combo Sujanu Most Heavily Pitched for GPs in May: Anterio
June 28, 2018
- AbbVie Eyes Global Simultaneous Launch for Autoimmune Disease Treatments: Exec
June 28, 2018
- Keytruda’s MSI-H Cancer Indication to Be Reviewed Under Conditional Early Approval System
June 28, 2018
- Chugai Chairman Prods Drug Makers to Innovate, Chides Calls for Relaxed Pricing
June 27, 2018
- FDA Decision on Shionogi’s Single-Dose Drug Expected by Dec. 24
June 27, 2018
- Rohto Takes 15% Stake in Shionogi’s Consumer Healthcare Unit
June 26, 2018
- Lonsurf Cuts Risk of Death by 31% in Metastatic Gastric Cancer
June 26, 2018
- Meiji, Hiroshima Univ. Spinout Hook Up on Cell Therapies for Osteoarthritis
June 26, 2018
- Xofluza Likely to Jolt Japan Flu Market This Winter
June 25, 2018
- J-TEC Enters License Agreement on Low-Cost Manufacturing of CAR-T Cells with 2 Universities
June 25, 2018
- Kowa Sues Towa for Damages Caused by Livalo Generics
June 25, 2018
- Generic Specialist Ohara to Develop Novel Liver Cirrhosis Treatment Licensed from Japanese Startup
June 25, 2018
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…